FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News

WHO's Tedros Says Uganda Should Reconsider Congo Border Closure Over Ebola

The director-general of the World Health Organization said on Monday ⁠that Uganda should reconsider its decision to close its border with Democratic ⁠Republic of Congo...

AI Brings Oxygen Therapy Closer to Autopilot

EMILY.AI uses AI to personalize oxygen delivery in real time, aiming for safer saturation control and fewer manual adjustments.

Ontario Researchers Discover Promising Antibiotic

McMaster University researchers have discovered a new antibiotic that kills drug-resistant bacteria through a previously unrecognized mechanism of action.

Lyme Primer: How the HHS Strategy Stacks Up To Science

Experts support targeting ticks but caution against the long-term use of antibiotics.

TNFi Use in Early Peripheral SpA Outperforms Methotrexate

‘These data [from the phase 3 SPARTACUS trial] support the importance of early diagnosis and early treatment before structural damage,’ said one expert not involved in the research.

FDA Approves First New Sunscreen Option in Two Decades

Bemotrizinol protects against both ultraviolet A and B rays, has low absorption through the skin, and is safe for adults and children 6 months and older, according to the FDA.

Todays Updates

Simpler Screening Criteria Could Catch More Lung Cancers

A study of nearly 1 million veterans suggests that simpler lung cancer screening eligibility — based on smoking duration — would sharply reduce missed cancers and narrow disparities.

Breast Cancer Genetic Testing Need in Black Women Identified

A large population study of young Black women aged 50 years or younger with invasive breast cancer highlights the importance of genetic testing in this population.

NHS Offers Targeted Radiotherapy for Early Prostate Cancer

Eligible men with early prostate cancer can now be offered a high-precision radiotherapy technique on the NHS in England.

Todays Updates

Simpler Screening Criteria Could Catch More Lung Cancers

A study of nearly 1 million veterans suggests that simpler lung cancer screening eligibility — based on smoking duration — would sharply reduce missed cancers and narrow disparities.

Breast Cancer Genetic Testing Need in Black Women Identified

A large population study of young Black women aged 50 years or younger with invasive breast cancer highlights the importance of genetic testing in this population.

NHS Offers Targeted Radiotherapy for Early Prostate Cancer

Eligible men with early prostate cancer can now be offered a high-precision radiotherapy technique on the NHS in England.

Latest News

The director-general of the World Health Organization said on Monday ⁠that Uganda should reconsider its decision to close its border with Democratic ⁠Republic of Congo...

EMILY.AI uses AI to personalize oxygen delivery in real time, aiming for safer saturation control and fewer manual adjustments.

McMaster University researchers have discovered a new antibiotic that kills drug-resistant bacteria through a previously unrecognized mechanism of action.

Experts support targeting ticks but caution against the long-term use of antibiotics.

‘These data [from the phase 3 SPARTACUS trial] support the importance of early diagnosis and early treatment before structural damage,’ said one expert not involved in the research.

Bemotrizinol protects against both ultraviolet A and B rays, has low absorption through the skin, and is safe for adults and children 6 months and older, according to the FDA.

News All Time

SARS-CoV-2 Poses Greater Autoimmune Risk Than Vaccines

Spanish dermatologists report that vaccine-related skin eruptions are uncommon, while SARS-CoV-2 infection itself is more strongly linked to autoimmune and vascular complications.

When Your Loved Ones Trust TikTok Over Their Doctor — & You

Physicians recount how health disinformation damaged close relationships and forced them to rethink how to advise loved ones.

Bimekizumab Trumps Risankizumab in Head-to-Head PsA Trial

Dual IL-17A/F inhibition was superior to IL-23 inhibition for managing joint involvement in psoriatic arthritis, according to findings from the phase 3b BE BOLD study.

Professional Corner: Groups Decry Medicaid Work Requirement

Societies say a federal policy may reduce access to care. The American Academy of Pediatrics updates its guidance on generic drugs. And a new research network focuses on heart transplant outcomes.

Why Cosmetic Surgery Abroad Can Backfire

Lower prices are drawing patients abroad for cosmetic surgery, but variable surgical expertise, limited follow-up care, and serious postoperative complications can quickly erase the savings.

Mepolizumab Boosts Quality of Life in CRSwNP

Mepolizumab improves disease-specific quality of life, reduces polyp burden, and improves asthma control in patients with severe chronic rhinosinusitis with nasal polyps, a real-world study shows.

Early Eosinophil Counts Affect Asthma in Pregnancy

Periconception levels show potential as a clinically useful marker for patients at risk.

MHRA Begins Review of Avacopan for Autoimmune Vasculitis

The UK’s drugs regulator is reviewing the integrity of trial data underpinning avacopan's licence for ANCA-associated vasculitis.

Ruto Says US Plan to Build Ebola Facility in Kenya Is the 'right Thing'

Kenyan President William Ruto on Thursday said his government was doing "the right thing" by allowing the United States to set up an Ebola quarantine facility ⁠in...

US Domestic Treatment Centers Ready for Ebola Even as Kenya Plans Persist

Most of the 13 U.S. treatment centers in a government-funded hospital network for severe infectious diseases are ready to handle patients, including those with Ebola if...

Otsuka Says Kidney Disease Drug Preserves Function in Late-stage Study

Otsuka Pharmaceutical said on Thursday its drug in a late-stage study preserved kidney ⁠function over 12 months in patients with a type of autoimmune disease that affects...

How Doctors’ Regrets Evolve — and What to Do With Yours

New research suggests that time and aging change how people deal with regrets. Here’s what it could mean for doctors.

Obexelimab Lowers Flare Risk in Phase 3 IgG4-RD Trial

Weekly subcutaneous injections of the novel B-cell inhibitor obexelimab significantly reduces disease flares and lowers toxic steroid exposure in patients with active IgG4-related disease.

Anifrolumab Improves Multiple Sjögren Disease Measures

Early data from the ANISE-II study show that the lupus-approved treatment may also work well in managing Sjögren disease.

JAK1 Inhibitor Zemprocitinib Hits Targets in Refractory RA

Zemprocitinib, a next-generation JAK1 inhibitor, may tame rheumatoid arthritis that does not respond to at least one biologic disease-modifying antirheumatic drug, a phase 3 clinical trial finds.

Infection Risk in Lupus and RA: What Matters Most

Disease activity, organ involvement, and treatment choice all shape infection risk in lupus and rheumatoid arthritis, with new data highlighting where clinicians should focus.

Recommended News For You

Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk

Clinical trial could lead to new 'gold standard' test for prostate cancer detection

Proton Therapy Fails to Beat IMRT in Prostate Cancer

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.

A small rise in cancer was observed following the 1986 Chernobyl accident.

In Advanced Myxoid Liposarcoma, Is Trabectedin Winning?

Pancreatic cancer RNA vaccine shows durable T cell immunity

Recommended Articles For You

Lactic Acid-Linked lncRNAs in Wilms Tumor: Decoding the Tumor Microenvironment & Prognosis 

Discovering the Benefits of TNK: A Comprehensive Blog Article  

Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options 

Understanding the Rare Disease: Werner Syndrome Explained  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Using AI, one can find cancer risk factors.

2.

New Gene Therapy Nears EU Nod for Bladder Cancer

3.

How breast tissue density affects your risk of breast cancer

4.

Young adults who are obese are at risk for 17 different types of cancer in the future.

5.

Distinct results for patients with positive and negative pancreatic cancer who are treated with systemic therapy, chemotherapy, and radiation.

1.

Mechanistic Insights into Abraxane, Verzenio, and the Management of Chemotherapy-Induced Tachycardia

2.

CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma: A Comprehensive Review

3.

Analyzing the Mechanisms and Efficacy of Carboplatin, Abraxane, and Albumin-Bound Formulations

4.

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization

5.

Evolution of Cancer Care Through Developmental Therapeutics

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

2.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

3.

The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

5.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot